Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126196062 | 12619606 | 2 | F | 20160906 | 20160803 | 20160913 | EXP | GB-GILEAD-2016-0225955 | GILEAD | 46.00 | YR | A | F | Y | 0.00000 | 20160913 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126196062 | 12619606 | 1 | PS | TENOFOVIR DISOPROXIL FUMARATE. | TENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | U | U | 21356 | 245 | MG | TABLET | ||||||
| 126196062 | 12619606 | 2 | SS | EMTRIVA | EMTRICITABINE | 1 | Oral | 200 MG, UNK | U | U | 0 | 200 | MG | CAPSULE | |||||
| 126196062 | 12619606 | 3 | SS | COTRIMOXAZOLE | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | 80/400MG | U | U | 0 | ||||||||
| 126196062 | 12619606 | 4 | SS | COTRIMOXAZOLE | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Unknown | U | U | UNKNOWN | 0 | ||||||||
| 126196062 | 12619606 | 5 | SS | COTRIMOXAZOLE | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | 80/400MG | U | U | UNKNOWN | 0 | |||||||
| 126196062 | 12619606 | 6 | SS | DARUNAVIR | DARUNAVIR | 1 | Oral | 800 MG, UNK | U | U | 0 | 800 | MG | ||||||
| 126196062 | 12619606 | 7 | SS | NORVIR | RITONAVIR | 1 | Oral | U | U | UNKNOWN | 0 | 100 | MG | ||||||
| 126196062 | 12619606 | 8 | SS | PROPRANOLOL | PROPRANOLOLPROPRANOLOL HYDROCHLORIDE | 1 | Oral | 40 MG, UNK | U | U | 0 | 40 | MG | ||||||
| 126196062 | 12619606 | 9 | SS | PROPRANOLOL | PROPRANOLOLPROPRANOLOL HYDROCHLORIDE | 1 | Unknown | U | U | UNKNOWN | 0 | 40 | MG | ||||||
| 126196062 | 12619606 | 10 | SS | PROPRANOLOL | PROPRANOLOLPROPRANOLOL HYDROCHLORIDE | 1 | Oral | 40.0MG UNKNOWN | U | U | UNKNOWN | 0 | 40 | MG | |||||
| 126196062 | 12619606 | 11 | SS | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Oral | 100 MG, UNK | U | U | 0 | 100 | MG | ||||||
| 126196062 | 12619606 | 12 | SS | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Unknown | U | U | UNKNOWN | 0 | 100 | MG | ||||||
| 126196062 | 12619606 | 13 | SS | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Oral | 100.0MG UNKNOWN | U | U | UNKNOWN | 0 | 100 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126196062 | 12619606 | 1 | HIV infection |
| 126196062 | 12619606 | 2 | HIV infection |
| 126196062 | 12619606 | 3 | Product used for unknown indication |
| 126196062 | 12619606 | 6 | HIV infection |
| 126196062 | 12619606 | 7 | HIV infection |
| 126196062 | 12619606 | 8 | Product used for unknown indication |
| 126196062 | 12619606 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126196062 | 12619606 | OT |
| 126196062 | 12619606 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126196062 | 12619606 | Cerebrovascular accident |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |